loader2
Partner With Us NRI

Welcure Drugs & Pharmaceuticals Ltd share Price Today

Company details

4.40
4.40
3.20
5.48
6M Return 10.55%
1Y Return 10.83%
Mkt Cap.(Cr) 5.95
Volume 10,366
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 10,366

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Welcure Drugs & Pharmaceuticals Ltd shares SWOT Analysis

Strengths (3)

  • Strong Annual EPS Growth
  • Company with No Debt
  • Book Value per share Improving for last 2 years

Weakness (5)

  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years
  • Inefficient use of shareholder funds - ROE declining in the last 2 years
  • Inefficient use of assets to generate profits - ROA declining in the last 2 years

Opportunity (0)

Data not found

Threats (1)

  • High PE (PE > 40)

Resistance and support

R1 4.4
R2 4.4
R3 4.4
Pivot

4.40

S1 4.4
S2 4.4
S3 4.4
EMA SMA
4.5
4.5
4.4
4.4
4.3
4.5
4.4
4.1
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
BHAGWAN AGARWAL Bulk Purchase 2024-01-17 4.87 100000 BSE
SYEDUMAR Bulk Sell 2022-12-14 5.66 73500 BSE
PARESH DHIRAJLAL SHAH Bulk Purchase 2022-12-06 5.3 67776 BSE
  • 100%
  • 0%
  • 0%
Name Category Shares
SHUBHAM GARG PUBLIC 1.91%
VINOD K S PUBLIC 1.5%
HUF PUBLIC 1.49%
VIZWISE COMMERCE PRIVATE LIMITED PUBLIC 2.24%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Welcure Drugs & Pharmaceuticals Ltd Stocks COMPARISON

Financials( in Cr) Welcure Drugs & Pharmaceuticals Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Dr Reddys Laboratories Ltd Divis Laboratories Ltd
Price 4.40 1,522.80 1,345.75 5,942.85 3,671.70
% Change -0.45 0.42 -0.12 -0.24 -1
Mcap Cr 5.95 365,370.73 108,649.13 99,132.09 97,472.25
Revenue TTM Cr 0.00 43,885.68 15,790.60 24,669.70 7,767.51
Net Profit TTM Cr 0.10 8,560.84 2,513.47 4,507.30 1,823.38
PE TTM 0.00 38.94 27.47 18.96 70.43
1 Year Return 10.83 51.55 45.60 20.98 12.26
ROCE 0.62 16.79 14.76 25.99 19.30
ROE 0.62 16.46 10.66 21.21 14.89
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 1.52 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 22,130.95 -8,253.26
LAST 3M 82,644.28 32,012.97
LAST 6M 141,441.37 66,162.53
LAST 12M 215,515.77 196,008.04

Welcure Drugs & Pharmaceuticals Ltd Information

Stock PE (TTM)
0
Promoter Holding
0%
Book Value
1.0791
ROCE
0.62%
ROE
0.62%
Description
  • Incorporated on 4 Jun.`92, Welcure Drugs And Pharmaceuticals (WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain. The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.`94 to part-finance the Rs 7-cr project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL). The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.`96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations. It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen. It manufactures over a hundred varieties of tablets, capsules and dry syrups, sulpha drugs, vitamins, analgesics, etc. Its subsidiary, AKL, manufactures 6-APA, a key drug intermediate in the manufacture of semi-synthetic penicillin. The company has decided to set up new sections of paediatrics and veterinary drugs and to diversify into ointments and liquid syrups. The new products of the company WELSTAP , X- CLOX , ETHAMBUTOL, RIFA- Z , CETIRIZIN , NORTIN have been well accepted in the market. The Company has entered into a collaboration agreement with a russian company to act as their sole selling agent for a unique medicine Stevioside, an alternate to sugar, Saccharin and Aspartame. The Company has added a new liquid oral plant in Bhiwadi, Rajasthan. It has obtained ISO 9002 certification with double accredition from ABS Quality Evaluation Inc Texas and by Registrar of Accredition Board of USA. Welcure has also entered into an agreement with Bihar Drugs and Chemicals Ltd, a government of Bihar undertaking, for manufacturing their products in its factory on loan basis. During the year 2000-01 the company had launched some products like CEZEN,DIMCIN PLUS,OXIN,SPASWIN etc.The company has entered into technical collaboration agreement with Advanced Medical Care Inc New Jersey USA for setting up of joint venture facilities in the existing plant of the company. During the year 2001-02, the company had launched products like B-ZEX, DMART PLUS, DRALPIN, DUKESPAS, DUBAMOL, HISTACURE, KUFFWEL, KINGSPAS, LANAX, PETRIMAX, PEEROSCAM, RENACT, SARVO, WELCEE, WELGESIC, WELIC, WELOXY, WELRELEEF, X-DRYL. It changed its marketing policy from "Sales through Wholesale Distributors" to " Sales at Doorstep" by reaching every corner of the country and by putting dual force on Sales-through sales personnel on one hand and through stockists and distributors on the other hand. The Company is carrying on the business of manufacturers, designers, repairers, installers, merchants, importers, exporters, agent for sale and distributors of and dealers in water processing equipment and purifiers, and water softeners of every description. Apart from these, it deals in real estate and engaged in creating exceptional living and working spaces for the new Indian global professionals.

No Data Found

AGM Date (Month) : Jul
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 524661
NSE Code :
Book Closure Date (Month) : Sep
BSE Group : X
ISIN : INE331C01017

FAQ’s on Welcure Drugs & Pharmaceuticals Ltd Shares

You can buy Welcure Drugs & Pharmaceuticals Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Welcure Drugs & Pharmaceuticals Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Apr 19, 2024 04:01 PM the closing price of Welcure Drugs & Pharmaceuticals Ltd was ₹ 4.40.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Apr 19, 2024 04:01 PM, the market cap of Welcure Drugs & Pharmaceuticals Ltd stood at ₹ 5.95.

The latest PE ratio of Welcure Drugs & Pharmaceuticals Ltd as of Apr 19, 2024 04:01 PM is 0

The latest PB ratio of Welcure Drugs & Pharmaceuticals Ltd as of Apr 19, 2024 04:01 PM is 0.25

The 52-week high of Welcure Drugs & Pharmaceuticals Ltd share price is ₹ 5.48 while the 52-week low is ₹ 3.20

Download Our

Download App
market app